Astragaloside IV

Cat. No.: 0225LY-1071

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Astragaloside IV is a bioactive saponin from Astragalus membranaceus that provides systemic protection for the nervous and cardiovascular systems; it suppresses JNK and ERK1/2 activation, reduces viral replication of HAdV-3, and downregulates MMP-2 and MMP-9 in breast cancer cells.

Synonym: AST-IV; AS-IV; 84687-43-4; Cyclosiversioside F; (2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; Astrasieversianin XIV; 3-O-beta-D-xylopyranosyl-6-O-beta-D-glucopyranosylcycloastragenol; (2R,3R,4S,5S,6R)-2-[[(1S,3R,8R,9S,11S,12S,14S,15R,16R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl; AstragalosideIV

CAS No.: 84687-43-4

Compound CID: 13943297

Formula: C₄₁H₆₈O₁₄

Formula Weight: 784.97

Specification

Relative Density: 1.39 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Astragaloside IV can be used in cardiovascular research or play an important role in studies on myocardial protection and anti-fibrotic mechanisms.